Zurich (awp) – The Swiss medical technology company is apparently preparing for an IPO next year. The Reuters news agency reported late on Monday, citing circles. Thus, the IPO of the company based in Castel San Pietro in Ticino could take place in the spring.
The company has mandated Credit Suisse and Morgan Stanley as leading institutions – JPMorgan and UBS are also involved. For now, only a minority of the shares should be sold to investors, he said.
The manufacturer of orthopedic implants Medacta employs about 930 employees and is expected to generate sales of about 300 million francs. The company specializes in knee and spine implants. Medacta is managed by the founder Alberto Siccardi.